Global Peptide CDMO Services Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global Peptide CDMO Services market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Peptide CDMO Services is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Peptide CDMO Services market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Peptide CDMO Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide CDMO Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide CDMO Services market.
Peptide CDMO services refer to peptide drug development and manufacturing outsourcing services. Polypeptides are short-chain proteins composed of amino acids and have a wide range of biological activities and pharmacological applications.
Peptide CDMO services usually cover the following aspects: peptide synthesis, process development, quality control, scale production, injection preparation. By choosing peptide CDMO services, the development and manufacture of peptide drugs can be handed over to professional institutions, thereby saving time, reducing costs, and ensuring product quality and compliance.
Key Features:
The report on Peptide CDMO Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide CDMO Services market. It may include historical data, market segmentation by Type (e.g., Small Molecule CDMO, Macro-molecular CDMO), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide CDMO Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide CDMO Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide CDMO Services industry. This include advancements in Peptide CDMO Services technology, Peptide CDMO Services new entrants, Peptide CDMO Services new investment, and other innovations that are shaping the future of Peptide CDMO Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide CDMO Services market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide CDMO Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide CDMO Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide CDMO Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide CDMO Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide CDMO Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide CDMO Services market.
Market Segmentation:
Peptide CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our (LP Info Research) latest study, the global Peptide CDMO Services market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Peptide CDMO Services is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Peptide CDMO Services market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Peptide CDMO Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Peptide CDMO Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Peptide CDMO Services market.
Peptide CDMO services refer to peptide drug development and manufacturing outsourcing services. Polypeptides are short-chain proteins composed of amino acids and have a wide range of biological activities and pharmacological applications.
Peptide CDMO services usually cover the following aspects: peptide synthesis, process development, quality control, scale production, injection preparation. By choosing peptide CDMO services, the development and manufacture of peptide drugs can be handed over to professional institutions, thereby saving time, reducing costs, and ensuring product quality and compliance.
Key Features:
The report on Peptide CDMO Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Peptide CDMO Services market. It may include historical data, market segmentation by Type (e.g., Small Molecule CDMO, Macro-molecular CDMO), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Peptide CDMO Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Peptide CDMO Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Peptide CDMO Services industry. This include advancements in Peptide CDMO Services technology, Peptide CDMO Services new entrants, Peptide CDMO Services new investment, and other innovations that are shaping the future of Peptide CDMO Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Peptide CDMO Services market. It includes factors influencing customer ' purchasing decisions, preferences for Peptide CDMO Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Peptide CDMO Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Peptide CDMO Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Peptide CDMO Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Peptide CDMO Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Peptide CDMO Services market.
Market Segmentation:
Peptide CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Small Molecule CDMO
- Macro-molecular CDMO
- Clinical Treatment
- Medical Research
- Commercial Production
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Incyte
- Gliead
- Boehringer Ingelheim
- Vertex
- Mirati Therapeutics
- AMPAC
- Pfizer
- Polypeptide
- Bachem
- Merck
- Asymchem
- Zhejiang Jiuzhou Pharmaceutical
- Sinopep
- Frontier Biotechnologies
- JYMed
- Chengdu Shengnuo Biotechnology
- Shanghai Soho-Yiming Pharmaceuticals
- Chinese Peptide Company
- Ambio Pharmaceuticals
- Zhejiang Peptites Biotech
- STA Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Services Market Size 2018-2029
2.1.2 Peptide CDMO Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peptide CDMO Services Segment by Type
2.2.1 Small Molecule CDMO
2.2.2 Macro-molecular CDMO
2.3 Peptide CDMO Services Market Size by Type
2.3.1 Peptide CDMO Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peptide CDMO Services Market Size Market Share by Type (2018-2023)
2.4 Peptide CDMO Services Segment by Application
2.4.1 Clinical Treatment
2.4.2 Medical Research
2.4.3 Commercial Production
2.5 Peptide CDMO Services Market Size by Application
2.5.1 Peptide CDMO Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peptide CDMO Services Market Size Market Share by Application (2018-2023)
3 PEPTIDE CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Peptide CDMO Services Market Size Market Share by Players
3.1.1 Global Peptide CDMO Services Revenue by Players (2018-2023)
3.1.2 Global Peptide CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Peptide CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO SERVICES BY REGIONS
4.1 Peptide CDMO Services Market Size by Regions (2018-2023)
4.2 Americas Peptide CDMO Services Market Size Growth (2018-2023)
4.3 APAC Peptide CDMO Services Market Size Growth (2018-2023)
4.4 Europe Peptide CDMO Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Peptide CDMO Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peptide CDMO Services Market Size by Country (2018-2023)
5.2 Americas Peptide CDMO Services Market Size by Type (2018-2023)
5.3 Americas Peptide CDMO Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Services Market Size by Region (2018-2023)
6.2 APAC Peptide CDMO Services Market Size by Type (2018-2023)
6.3 APAC Peptide CDMO Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO Services by Country (2018-2023)
7.2 Europe Peptide CDMO Services Market Size by Type (2018-2023)
7.3 Europe Peptide CDMO Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO Services by Region (2018-2023)
8.2 Middle East & Africa Peptide CDMO Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Peptide CDMO Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO SERVICES MARKET FORECAST
10.1 Global Peptide CDMO Services Forecast by Regions (2024-2029)
10.1.1 Global Peptide CDMO Services Forecast by Regions (2024-2029)
10.1.2 Americas Peptide CDMO Services Forecast
10.1.3 APAC Peptide CDMO Services Forecast
10.1.4 Europe Peptide CDMO Services Forecast
10.1.5 Middle East & Africa Peptide CDMO Services Forecast
10.2 Americas Peptide CDMO Services Forecast by Country (2024-2029)
10.2.1 United States Peptide CDMO Services Market Forecast
10.2.2 Canada Peptide CDMO Services Market Forecast
10.2.3 Mexico Peptide CDMO Services Market Forecast
10.2.4 Brazil Peptide CDMO Services Market Forecast
10.3 APAC Peptide CDMO Services Forecast by Region (2024-2029)
10.3.1 China Peptide CDMO Services Market Forecast
10.3.2 Japan Peptide CDMO Services Market Forecast
10.3.3 Korea Peptide CDMO Services Market Forecast
10.3.4 Southeast Asia Peptide CDMO Services Market Forecast
10.3.5 India Peptide CDMO Services Market Forecast
10.3.6 Australia Peptide CDMO Services Market Forecast
10.4 Europe Peptide CDMO Services Forecast by Country (2024-2029)
10.4.1 Germany Peptide CDMO Services Market Forecast
10.4.2 France Peptide CDMO Services Market Forecast
10.4.3 UK Peptide CDMO Services Market Forecast
10.4.4 Italy Peptide CDMO Services Market Forecast
10.4.5 Russia Peptide CDMO Services Market Forecast
10.5 Middle East & Africa Peptide CDMO Services Forecast by Region (2024-2029)
10.5.1 Egypt Peptide CDMO Services Market Forecast
10.5.2 South Africa Peptide CDMO Services Market Forecast
10.5.3 Israel Peptide CDMO Services Market Forecast
10.5.4 Turkey Peptide CDMO Services Market Forecast
10.5.5 GCC Countries Peptide CDMO Services Market Forecast
10.6 Global Peptide CDMO Services Forecast by Type (2024-2029)
10.7 Global Peptide CDMO Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Incyte
11.1.1 Incyte Company Information
11.1.2 Incyte Peptide CDMO Services Product Offered
11.1.3 Incyte Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Incyte Main Business Overview
11.1.5 Incyte Latest Developments
11.2 Gliead
11.2.1 Gliead Company Information
11.2.2 Gliead Peptide CDMO Services Product Offered
11.2.3 Gliead Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Gliead Main Business Overview
11.2.5 Gliead Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Peptide CDMO Services Product Offered
11.3.3 Boehringer Ingelheim Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
11.4.1 Vertex Company Information
11.4.2 Vertex Peptide CDMO Services Product Offered
11.4.3 Vertex Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vertex Main Business Overview
11.4.5 Vertex Latest Developments
11.5 Mirati Therapeutics
11.5.1 Mirati Therapeutics Company Information
11.5.2 Mirati Therapeutics Peptide CDMO Services Product Offered
11.5.3 Mirati Therapeutics Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mirati Therapeutics Main Business Overview
11.5.5 Mirati Therapeutics Latest Developments
11.6 AMPAC
11.6.1 AMPAC Company Information
11.6.2 AMPAC Peptide CDMO Services Product Offered
11.6.3 AMPAC Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AMPAC Main Business Overview
11.6.5 AMPAC Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Peptide CDMO Services Product Offered
11.7.3 Pfizer Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Polypeptide
11.8.1 Polypeptide Company Information
11.8.2 Polypeptide Peptide CDMO Services Product Offered
11.8.3 Polypeptide Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Polypeptide Main Business Overview
11.8.5 Polypeptide Latest Developments
11.9 Bachem
11.9.1 Bachem Company Information
11.9.2 Bachem Peptide CDMO Services Product Offered
11.9.3 Bachem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bachem Main Business Overview
11.9.5 Bachem Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Peptide CDMO Services Product Offered
11.10.3 Merck Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Asymchem
11.11.1 Asymchem Company Information
11.11.2 Asymchem Peptide CDMO Services Product Offered
11.11.3 Asymchem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Asymchem Main Business Overview
11.11.5 Asymchem Latest Developments
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Information
11.12.2 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product Offered
11.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview
11.12.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments
11.13 Sinopep
11.13.1 Sinopep Company Information
11.13.2 Sinopep Peptide CDMO Services Product Offered
11.13.3 Sinopep Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sinopep Main Business Overview
11.13.5 Sinopep Latest Developments
11.14 Frontier Biotechnologies
11.14.1 Frontier Biotechnologies Company Information
11.14.2 Frontier Biotechnologies Peptide CDMO Services Product Offered
11.14.3 Frontier Biotechnologies Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Frontier Biotechnologies Main Business Overview
11.14.5 Frontier Biotechnologies Latest Developments
11.15 JYMed
11.15.1 JYMed Company Information
11.15.2 JYMed Peptide CDMO Services Product Offered
11.15.3 JYMed Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 JYMed Main Business Overview
11.15.5 JYMed Latest Developments
11.16 Chengdu Shengnuo Biotechnology
11.16.1 Chengdu Shengnuo Biotechnology Company Information
11.16.2 Chengdu Shengnuo Biotechnology Peptide CDMO Services Product Offered
11.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Chengdu Shengnuo Biotechnology Main Business Overview
11.16.5 Chengdu Shengnuo Biotechnology Latest Developments
11.17 Shanghai Soho-Yiming Pharmaceuticals
11.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
11.17.2 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product Offered
11.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Shanghai Soho-Yiming Pharmaceuticals Main Business Overview
11.17.5 Shanghai Soho-Yiming Pharmaceuticals Latest Developments
11.18 Chinese Peptide Company
11.18.1 Chinese Peptide Company Company Information
11.18.2 Chinese Peptide Company Peptide CDMO Services Product Offered
11.18.3 Chinese Peptide Company Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Chinese Peptide Company Main Business Overview
11.18.5 Chinese Peptide Company Latest Developments
11.19 Ambio Pharmaceuticals
11.19.1 Ambio Pharmaceuticals Company Information
11.19.2 Ambio Pharmaceuticals Peptide CDMO Services Product Offered
11.19.3 Ambio Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Ambio Pharmaceuticals Main Business Overview
11.19.5 Ambio Pharmaceuticals Latest Developments
11.20 Zhejiang Peptites Biotech
11.20.1 Zhejiang Peptites Biotech Company Information
11.20.2 Zhejiang Peptites Biotech Peptide CDMO Services Product Offered
11.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Zhejiang Peptites Biotech Main Business Overview
11.20.5 Zhejiang Peptites Biotech Latest Developments
11.21 STA Pharmaceutical
11.21.1 STA Pharmaceutical Company Information
11.21.2 STA Pharmaceutical Peptide CDMO Services Product Offered
11.21.3 STA Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 STA Pharmaceutical Main Business Overview
11.21.5 STA Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide CDMO Services Market Size 2018-2029
2.1.2 Peptide CDMO Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Peptide CDMO Services Segment by Type
2.2.1 Small Molecule CDMO
2.2.2 Macro-molecular CDMO
2.3 Peptide CDMO Services Market Size by Type
2.3.1 Peptide CDMO Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Peptide CDMO Services Market Size Market Share by Type (2018-2023)
2.4 Peptide CDMO Services Segment by Application
2.4.1 Clinical Treatment
2.4.2 Medical Research
2.4.3 Commercial Production
2.5 Peptide CDMO Services Market Size by Application
2.5.1 Peptide CDMO Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Peptide CDMO Services Market Size Market Share by Application (2018-2023)
3 PEPTIDE CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Peptide CDMO Services Market Size Market Share by Players
3.1.1 Global Peptide CDMO Services Revenue by Players (2018-2023)
3.1.2 Global Peptide CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Peptide CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PEPTIDE CDMO SERVICES BY REGIONS
4.1 Peptide CDMO Services Market Size by Regions (2018-2023)
4.2 Americas Peptide CDMO Services Market Size Growth (2018-2023)
4.3 APAC Peptide CDMO Services Market Size Growth (2018-2023)
4.4 Europe Peptide CDMO Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Peptide CDMO Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Peptide CDMO Services Market Size by Country (2018-2023)
5.2 Americas Peptide CDMO Services Market Size by Type (2018-2023)
5.3 Americas Peptide CDMO Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide CDMO Services Market Size by Region (2018-2023)
6.2 APAC Peptide CDMO Services Market Size by Type (2018-2023)
6.3 APAC Peptide CDMO Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Peptide CDMO Services by Country (2018-2023)
7.2 Europe Peptide CDMO Services Market Size by Type (2018-2023)
7.3 Europe Peptide CDMO Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide CDMO Services by Region (2018-2023)
8.2 Middle East & Africa Peptide CDMO Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Peptide CDMO Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PEPTIDE CDMO SERVICES MARKET FORECAST
10.1 Global Peptide CDMO Services Forecast by Regions (2024-2029)
10.1.1 Global Peptide CDMO Services Forecast by Regions (2024-2029)
10.1.2 Americas Peptide CDMO Services Forecast
10.1.3 APAC Peptide CDMO Services Forecast
10.1.4 Europe Peptide CDMO Services Forecast
10.1.5 Middle East & Africa Peptide CDMO Services Forecast
10.2 Americas Peptide CDMO Services Forecast by Country (2024-2029)
10.2.1 United States Peptide CDMO Services Market Forecast
10.2.2 Canada Peptide CDMO Services Market Forecast
10.2.3 Mexico Peptide CDMO Services Market Forecast
10.2.4 Brazil Peptide CDMO Services Market Forecast
10.3 APAC Peptide CDMO Services Forecast by Region (2024-2029)
10.3.1 China Peptide CDMO Services Market Forecast
10.3.2 Japan Peptide CDMO Services Market Forecast
10.3.3 Korea Peptide CDMO Services Market Forecast
10.3.4 Southeast Asia Peptide CDMO Services Market Forecast
10.3.5 India Peptide CDMO Services Market Forecast
10.3.6 Australia Peptide CDMO Services Market Forecast
10.4 Europe Peptide CDMO Services Forecast by Country (2024-2029)
10.4.1 Germany Peptide CDMO Services Market Forecast
10.4.2 France Peptide CDMO Services Market Forecast
10.4.3 UK Peptide CDMO Services Market Forecast
10.4.4 Italy Peptide CDMO Services Market Forecast
10.4.5 Russia Peptide CDMO Services Market Forecast
10.5 Middle East & Africa Peptide CDMO Services Forecast by Region (2024-2029)
10.5.1 Egypt Peptide CDMO Services Market Forecast
10.5.2 South Africa Peptide CDMO Services Market Forecast
10.5.3 Israel Peptide CDMO Services Market Forecast
10.5.4 Turkey Peptide CDMO Services Market Forecast
10.5.5 GCC Countries Peptide CDMO Services Market Forecast
10.6 Global Peptide CDMO Services Forecast by Type (2024-2029)
10.7 Global Peptide CDMO Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Incyte
11.1.1 Incyte Company Information
11.1.2 Incyte Peptide CDMO Services Product Offered
11.1.3 Incyte Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Incyte Main Business Overview
11.1.5 Incyte Latest Developments
11.2 Gliead
11.2.1 Gliead Company Information
11.2.2 Gliead Peptide CDMO Services Product Offered
11.2.3 Gliead Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Gliead Main Business Overview
11.2.5 Gliead Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Peptide CDMO Services Product Offered
11.3.3 Boehringer Ingelheim Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Vertex
11.4.1 Vertex Company Information
11.4.2 Vertex Peptide CDMO Services Product Offered
11.4.3 Vertex Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vertex Main Business Overview
11.4.5 Vertex Latest Developments
11.5 Mirati Therapeutics
11.5.1 Mirati Therapeutics Company Information
11.5.2 Mirati Therapeutics Peptide CDMO Services Product Offered
11.5.3 Mirati Therapeutics Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mirati Therapeutics Main Business Overview
11.5.5 Mirati Therapeutics Latest Developments
11.6 AMPAC
11.6.1 AMPAC Company Information
11.6.2 AMPAC Peptide CDMO Services Product Offered
11.6.3 AMPAC Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AMPAC Main Business Overview
11.6.5 AMPAC Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Peptide CDMO Services Product Offered
11.7.3 Pfizer Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Polypeptide
11.8.1 Polypeptide Company Information
11.8.2 Polypeptide Peptide CDMO Services Product Offered
11.8.3 Polypeptide Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Polypeptide Main Business Overview
11.8.5 Polypeptide Latest Developments
11.9 Bachem
11.9.1 Bachem Company Information
11.9.2 Bachem Peptide CDMO Services Product Offered
11.9.3 Bachem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bachem Main Business Overview
11.9.5 Bachem Latest Developments
11.10 Merck
11.10.1 Merck Company Information
11.10.2 Merck Peptide CDMO Services Product Offered
11.10.3 Merck Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Merck Main Business Overview
11.10.5 Merck Latest Developments
11.11 Asymchem
11.11.1 Asymchem Company Information
11.11.2 Asymchem Peptide CDMO Services Product Offered
11.11.3 Asymchem Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Asymchem Main Business Overview
11.11.5 Asymchem Latest Developments
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Information
11.12.2 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product Offered
11.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Zhejiang Jiuzhou Pharmaceutical Main Business Overview
11.12.5 Zhejiang Jiuzhou Pharmaceutical Latest Developments
11.13 Sinopep
11.13.1 Sinopep Company Information
11.13.2 Sinopep Peptide CDMO Services Product Offered
11.13.3 Sinopep Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Sinopep Main Business Overview
11.13.5 Sinopep Latest Developments
11.14 Frontier Biotechnologies
11.14.1 Frontier Biotechnologies Company Information
11.14.2 Frontier Biotechnologies Peptide CDMO Services Product Offered
11.14.3 Frontier Biotechnologies Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Frontier Biotechnologies Main Business Overview
11.14.5 Frontier Biotechnologies Latest Developments
11.15 JYMed
11.15.1 JYMed Company Information
11.15.2 JYMed Peptide CDMO Services Product Offered
11.15.3 JYMed Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 JYMed Main Business Overview
11.15.5 JYMed Latest Developments
11.16 Chengdu Shengnuo Biotechnology
11.16.1 Chengdu Shengnuo Biotechnology Company Information
11.16.2 Chengdu Shengnuo Biotechnology Peptide CDMO Services Product Offered
11.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Chengdu Shengnuo Biotechnology Main Business Overview
11.16.5 Chengdu Shengnuo Biotechnology Latest Developments
11.17 Shanghai Soho-Yiming Pharmaceuticals
11.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
11.17.2 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product Offered
11.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Shanghai Soho-Yiming Pharmaceuticals Main Business Overview
11.17.5 Shanghai Soho-Yiming Pharmaceuticals Latest Developments
11.18 Chinese Peptide Company
11.18.1 Chinese Peptide Company Company Information
11.18.2 Chinese Peptide Company Peptide CDMO Services Product Offered
11.18.3 Chinese Peptide Company Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Chinese Peptide Company Main Business Overview
11.18.5 Chinese Peptide Company Latest Developments
11.19 Ambio Pharmaceuticals
11.19.1 Ambio Pharmaceuticals Company Information
11.19.2 Ambio Pharmaceuticals Peptide CDMO Services Product Offered
11.19.3 Ambio Pharmaceuticals Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Ambio Pharmaceuticals Main Business Overview
11.19.5 Ambio Pharmaceuticals Latest Developments
11.20 Zhejiang Peptites Biotech
11.20.1 Zhejiang Peptites Biotech Company Information
11.20.2 Zhejiang Peptites Biotech Peptide CDMO Services Product Offered
11.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Zhejiang Peptites Biotech Main Business Overview
11.20.5 Zhejiang Peptites Biotech Latest Developments
11.21 STA Pharmaceutical
11.21.1 STA Pharmaceutical Company Information
11.21.2 STA Pharmaceutical Peptide CDMO Services Product Offered
11.21.3 STA Pharmaceutical Peptide CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 STA Pharmaceutical Main Business Overview
11.21.5 STA Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peptide CDMO Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Small Molecule CDMO
Table 3. Major Players of Macro-molecular CDMO
Table 4. Peptide CDMO Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 7. Peptide CDMO Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 10. Global Peptide CDMO Services Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Peptide CDMO Services Revenue Market Share by Player (2018-2023)
Table 12. Peptide CDMO Services Key Players Head office and Products Offered
Table 13. Peptide CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Peptide CDMO Services Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Peptide CDMO Services Market Size Market Share by Regions (2018-2023)
Table 18. Global Peptide CDMO Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Peptide CDMO Services Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Peptide CDMO Services Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Peptide CDMO Services Market Size Market Share by Country (2018-2023)
Table 22. Americas Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 24. Americas Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 26. APAC Peptide CDMO Services Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Table 28. APAC Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 30. APAC Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 32. Europe Peptide CDMO Services Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Peptide CDMO Services Market Size Market Share by Country (2018-2023)
Table 34. Europe Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 36. Europe Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Peptide CDMO Services Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Peptide CDMO Services
Table 45. Key Market Challenges & Risks of Peptide CDMO Services
Table 46. Key Industry Trends of Peptide CDMO Services
Table 47. Global Peptide CDMO Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Peptide CDMO Services Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Peptide CDMO Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Peptide CDMO Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Incyte Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 52. Incyte Peptide CDMO Services Product Offered
Table 53. Incyte Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Incyte Main Business
Table 55. Incyte Latest Developments
Table 56. Gliead Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 57. Gliead Peptide CDMO Services Product Offered
Table 58. Gliead Main Business
Table 59. Gliead Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Gliead Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 62. Boehringer Ingelheim Peptide CDMO Services Product Offered
Table 63. Boehringer Ingelheim Main Business
Table 64. Boehringer Ingelheim Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Vertex Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 67. Vertex Peptide CDMO Services Product Offered
Table 68. Vertex Main Business
Table 69. Vertex Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vertex Latest Developments
Table 71. Mirati Therapeutics Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 72. Mirati Therapeutics Peptide CDMO Services Product Offered
Table 73. Mirati Therapeutics Main Business
Table 74. Mirati Therapeutics Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Mirati Therapeutics Latest Developments
Table 76. AMPAC Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 77. AMPAC Peptide CDMO Services Product Offered
Table 78. AMPAC Main Business
Table 79. AMPAC Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. AMPAC Latest Developments
Table 81. Pfizer Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 82. Pfizer Peptide CDMO Services Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Pfizer Latest Developments
Table 86. Polypeptide Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 87. Polypeptide Peptide CDMO Services Product Offered
Table 88. Polypeptide Main Business
Table 89. Polypeptide Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Polypeptide Latest Developments
Table 91. Bachem Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 92. Bachem Peptide CDMO Services Product Offered
Table 93. Bachem Main Business
Table 94. Bachem Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bachem Latest Developments
Table 96. Merck Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 97. Merck Peptide CDMO Services Product Offered
Table 98. Merck Main Business
Table 99. Merck Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Merck Latest Developments
Table 101. Asymchem Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 102. Asymchem Peptide CDMO Services Product Offered
Table 103. Asymchem Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Asymchem Main Business
Table 105. Asymchem Latest Developments
Table 106. Zhejiang Jiuzhou Pharmaceutical Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 107. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product Offered
Table 108. Zhejiang Jiuzhou Pharmaceutical Main Business
Table 109. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Zhejiang Jiuzhou Pharmaceutical Latest Developments
Table 111. Sinopep Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 112. Sinopep Peptide CDMO Services Product Offered
Table 113. Sinopep Main Business
Table 114. Sinopep Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Sinopep Latest Developments
Table 116. Frontier Biotechnologies Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 117. Frontier Biotechnologies Peptide CDMO Services Product Offered
Table 118. Frontier Biotechnologies Main Business
Table 119. Frontier Biotechnologies Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Frontier Biotechnologies Latest Developments
Table 121. JYMed Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 122. JYMed Peptide CDMO Services Product Offered
Table 123. JYMed Main Business
Table 124. JYMed Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. JYMed Latest Developments
Table 126. Chengdu Shengnuo Biotechnology Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 127. Chengdu Shengnuo Biotechnology Peptide CDMO Services Product Offered
Table 128. Chengdu Shengnuo Biotechnology Main Business
Table 129. Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Chengdu Shengnuo Biotechnology Latest Developments
Table 131. Shanghai Soho-Yiming Pharmaceuticals Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 132. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product Offered
Table 133. Shanghai Soho-Yiming Pharmaceuticals Main Business
Table 134. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Latest Developments
Table 136. Chinese Peptide Company Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 137. Chinese Peptide Company Peptide CDMO Services Product Offered
Table 138. Chinese Peptide Company Main Business
Table 139. Chinese Peptide Company Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Chinese Peptide Company Latest Developments
Table 141. Ambio Pharmaceuticals Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 142. Ambio Pharmaceuticals Peptide CDMO Services Product Offered
Table 143. Ambio Pharmaceuticals Main Business
Table 144. Ambio Pharmaceuticals Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Ambio Pharmaceuticals Latest Developments
Table 146. Zhejiang Peptites Biotech Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 147. Zhejiang Peptites Biotech Peptide CDMO Services Product Offered
Table 148. Zhejiang Peptites Biotech Main Business
Table 149. Zhejiang Peptites Biotech Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Zhejiang Peptites Biotech Latest Developments
Table 151. STA Pharmaceutical Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 152. STA Pharmaceutical Peptide CDMO Services Product Offered
Table 153. STA Pharmaceutical Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. STA Pharmaceutical Main Business
Table 155. STA Pharmaceutical Latest Developments
Table 1. Peptide CDMO Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Small Molecule CDMO
Table 3. Major Players of Macro-molecular CDMO
Table 4. Peptide CDMO Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 7. Peptide CDMO Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 10. Global Peptide CDMO Services Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Peptide CDMO Services Revenue Market Share by Player (2018-2023)
Table 12. Peptide CDMO Services Key Players Head office and Products Offered
Table 13. Peptide CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Peptide CDMO Services Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Peptide CDMO Services Market Size Market Share by Regions (2018-2023)
Table 18. Global Peptide CDMO Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Peptide CDMO Services Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Peptide CDMO Services Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Peptide CDMO Services Market Size Market Share by Country (2018-2023)
Table 22. Americas Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 24. Americas Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 26. APAC Peptide CDMO Services Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Table 28. APAC Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 30. APAC Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 32. Europe Peptide CDMO Services Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Peptide CDMO Services Market Size Market Share by Country (2018-2023)
Table 34. Europe Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 36. Europe Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Peptide CDMO Services Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Peptide CDMO Services Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Peptide CDMO Services Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Peptide CDMO Services
Table 45. Key Market Challenges & Risks of Peptide CDMO Services
Table 46. Key Industry Trends of Peptide CDMO Services
Table 47. Global Peptide CDMO Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Peptide CDMO Services Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Peptide CDMO Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Peptide CDMO Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Incyte Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 52. Incyte Peptide CDMO Services Product Offered
Table 53. Incyte Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Incyte Main Business
Table 55. Incyte Latest Developments
Table 56. Gliead Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 57. Gliead Peptide CDMO Services Product Offered
Table 58. Gliead Main Business
Table 59. Gliead Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Gliead Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 62. Boehringer Ingelheim Peptide CDMO Services Product Offered
Table 63. Boehringer Ingelheim Main Business
Table 64. Boehringer Ingelheim Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Vertex Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 67. Vertex Peptide CDMO Services Product Offered
Table 68. Vertex Main Business
Table 69. Vertex Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vertex Latest Developments
Table 71. Mirati Therapeutics Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 72. Mirati Therapeutics Peptide CDMO Services Product Offered
Table 73. Mirati Therapeutics Main Business
Table 74. Mirati Therapeutics Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Mirati Therapeutics Latest Developments
Table 76. AMPAC Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 77. AMPAC Peptide CDMO Services Product Offered
Table 78. AMPAC Main Business
Table 79. AMPAC Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. AMPAC Latest Developments
Table 81. Pfizer Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 82. Pfizer Peptide CDMO Services Product Offered
Table 83. Pfizer Main Business
Table 84. Pfizer Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Pfizer Latest Developments
Table 86. Polypeptide Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 87. Polypeptide Peptide CDMO Services Product Offered
Table 88. Polypeptide Main Business
Table 89. Polypeptide Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Polypeptide Latest Developments
Table 91. Bachem Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 92. Bachem Peptide CDMO Services Product Offered
Table 93. Bachem Main Business
Table 94. Bachem Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Bachem Latest Developments
Table 96. Merck Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 97. Merck Peptide CDMO Services Product Offered
Table 98. Merck Main Business
Table 99. Merck Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Merck Latest Developments
Table 101. Asymchem Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 102. Asymchem Peptide CDMO Services Product Offered
Table 103. Asymchem Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Asymchem Main Business
Table 105. Asymchem Latest Developments
Table 106. Zhejiang Jiuzhou Pharmaceutical Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 107. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product Offered
Table 108. Zhejiang Jiuzhou Pharmaceutical Main Business
Table 109. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Zhejiang Jiuzhou Pharmaceutical Latest Developments
Table 111. Sinopep Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 112. Sinopep Peptide CDMO Services Product Offered
Table 113. Sinopep Main Business
Table 114. Sinopep Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Sinopep Latest Developments
Table 116. Frontier Biotechnologies Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 117. Frontier Biotechnologies Peptide CDMO Services Product Offered
Table 118. Frontier Biotechnologies Main Business
Table 119. Frontier Biotechnologies Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Frontier Biotechnologies Latest Developments
Table 121. JYMed Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 122. JYMed Peptide CDMO Services Product Offered
Table 123. JYMed Main Business
Table 124. JYMed Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. JYMed Latest Developments
Table 126. Chengdu Shengnuo Biotechnology Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 127. Chengdu Shengnuo Biotechnology Peptide CDMO Services Product Offered
Table 128. Chengdu Shengnuo Biotechnology Main Business
Table 129. Chengdu Shengnuo Biotechnology Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Chengdu Shengnuo Biotechnology Latest Developments
Table 131. Shanghai Soho-Yiming Pharmaceuticals Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 132. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product Offered
Table 133. Shanghai Soho-Yiming Pharmaceuticals Main Business
Table 134. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Latest Developments
Table 136. Chinese Peptide Company Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 137. Chinese Peptide Company Peptide CDMO Services Product Offered
Table 138. Chinese Peptide Company Main Business
Table 139. Chinese Peptide Company Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Chinese Peptide Company Latest Developments
Table 141. Ambio Pharmaceuticals Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 142. Ambio Pharmaceuticals Peptide CDMO Services Product Offered
Table 143. Ambio Pharmaceuticals Main Business
Table 144. Ambio Pharmaceuticals Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Ambio Pharmaceuticals Latest Developments
Table 146. Zhejiang Peptites Biotech Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 147. Zhejiang Peptites Biotech Peptide CDMO Services Product Offered
Table 148. Zhejiang Peptites Biotech Main Business
Table 149. Zhejiang Peptites Biotech Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Zhejiang Peptites Biotech Latest Developments
Table 151. STA Pharmaceutical Details, Company Type, Peptide CDMO Services Area Served and Its Competitors
Table 152. STA Pharmaceutical Peptide CDMO Services Product Offered
Table 153. STA Pharmaceutical Peptide CDMO Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. STA Pharmaceutical Main Business
Table 155. STA Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Peptide CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peptide CDMO Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peptide CDMO Services Sales Market Share by Country/Region (2022)
Figure 8. Peptide CDMO Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peptide CDMO Services Market Size Market Share by Type in 2022
Figure 10. Peptide CDMO Services in Clinical Treatment
Figure 11. Global Peptide CDMO Services Market: Clinical Treatment (2018-2023) & ($ Millions)
Figure 12. Peptide CDMO Services in Medical Research
Figure 13. Global Peptide CDMO Services Market: Medical Research (2018-2023) & ($ Millions)
Figure 14. Peptide CDMO Services in Commercial Production
Figure 15. Global Peptide CDMO Services Market: Commercial Production (2018-2023) & ($ Millions)
Figure 16. Global Peptide CDMO Services Market Size Market Share by Application in 2022
Figure 17. Global Peptide CDMO Services Revenue Market Share by Player in 2022
Figure 18. Global Peptide CDMO Services Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 20. APAC Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 21. Europe Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 23. Americas Peptide CDMO Services Value Market Share by Country in 2022
Figure 24. United States Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Peptide CDMO Services Market Size Market Share by Region in 2022
Figure 29. APAC Peptide CDMO Services Market Size Market Share by Type in 2022
Figure 30. APAC Peptide CDMO Services Market Size Market Share by Application in 2022
Figure 31. China Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Peptide CDMO Services Market Size Market Share by Country in 2022
Figure 38. Europe Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Figure 39. Europe Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Figure 40. Germany Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 54. APAC Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 55. Europe Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 57. United States Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 58. Canada Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 61. China Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 62. Japan Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 63. Korea Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 65. India Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 66. Australia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 67. Germany Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 68. France Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 69. UK Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 70. Italy Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 71. Russia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 72. Spain Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 75. Israel Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 78. Global Peptide CDMO Services Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Peptide CDMO Services Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Peptide CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peptide CDMO Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Peptide CDMO Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Peptide CDMO Services Sales Market Share by Country/Region (2022)
Figure 8. Peptide CDMO Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Peptide CDMO Services Market Size Market Share by Type in 2022
Figure 10. Peptide CDMO Services in Clinical Treatment
Figure 11. Global Peptide CDMO Services Market: Clinical Treatment (2018-2023) & ($ Millions)
Figure 12. Peptide CDMO Services in Medical Research
Figure 13. Global Peptide CDMO Services Market: Medical Research (2018-2023) & ($ Millions)
Figure 14. Peptide CDMO Services in Commercial Production
Figure 15. Global Peptide CDMO Services Market: Commercial Production (2018-2023) & ($ Millions)
Figure 16. Global Peptide CDMO Services Market Size Market Share by Application in 2022
Figure 17. Global Peptide CDMO Services Revenue Market Share by Player in 2022
Figure 18. Global Peptide CDMO Services Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 20. APAC Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 21. Europe Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Peptide CDMO Services Market Size 2018-2023 ($ Millions)
Figure 23. Americas Peptide CDMO Services Value Market Share by Country in 2022
Figure 24. United States Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Peptide CDMO Services Market Size Market Share by Region in 2022
Figure 29. APAC Peptide CDMO Services Market Size Market Share by Type in 2022
Figure 30. APAC Peptide CDMO Services Market Size Market Share by Application in 2022
Figure 31. China Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Peptide CDMO Services Market Size Market Share by Country in 2022
Figure 38. Europe Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Figure 39. Europe Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Figure 40. Germany Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Peptide CDMO Services Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Peptide CDMO Services Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Peptide CDMO Services Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Peptide CDMO Services Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 54. APAC Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 55. Europe Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 57. United States Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 58. Canada Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 61. China Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 62. Japan Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 63. Korea Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 65. India Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 66. Australia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 67. Germany Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 68. France Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 69. UK Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 70. Italy Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 71. Russia Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 72. Spain Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 75. Israel Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Peptide CDMO Services Market Size 2024-2029 ($ Millions)
Figure 78. Global Peptide CDMO Services Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Peptide CDMO Services Market Size Market Share Forecast by Application (2024-2029)
